BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21889274)

  • 1. Current strategic approaches for the detection of blood doping practices.
    Segura J; Ventura R; Pascual JA
    Forensic Sci Int; 2011 Dec; 213(1-3):42-8. PubMed ID: 21889274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection methods for autologous blood doping.
    Segura J; Monfort N; Ventura R
    Drug Test Anal; 2012 Nov; 4(11):876-81. PubMed ID: 22407819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of autologous blood transfusions in athletes: a historical perspective.
    Mørkeberg J
    Transfus Med Rev; 2012 Jul; 26(3):199-208. PubMed ID: 22119492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood transfusions in athletes. Old dogmas, new tricks.
    Lippi G; Banfi G
    Clin Chem Lab Med; 2006; 44(12):1395-402. PubMed ID: 17163813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting autologous blood transfusions: a comparison of three passport approaches and four blood markers.
    Mørkeberg J; Sharpe K; Belhage B; Damsgaard R; Schmidt W; Prommer N; Gore CJ; Ashenden MJ
    Scand J Med Sci Sports; 2011 Apr; 21(2):235-43. PubMed ID: 19903320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker monitoring in sports doping control.
    Pottgiesser T; Schumacher YO
    Bioanalysis; 2012 Jun; 4(10):1245-53. PubMed ID: 22651568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin mass and biological passport for the detection of autologous blood doping.
    Pottgiesser T; Echteler T; Sottas PE; Umhau M; Schumacher YO
    Med Sci Sports Exerc; 2012 May; 44(5):835-43. PubMed ID: 21988933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematologic passport for athletes competing in endurance sports: a feasibility study.
    Malcovati L; Pascutto C; Cazzola M
    Haematologica; 2003 May; 88(5):570-81. PubMed ID: 12745277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oxygen blood transport and doping].
    Audran M; Connes P; Varlet-Marie E
    Bull Acad Natl Med; 2003; 187(9):1669-79; discussion 1680-3. PubMed ID: 15369237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood doping in athletes--detection of allogeneic blood transfusions by flow cytofluorometry.
    Arndt PA; Kumpel BM
    Am J Hematol; 2008 Aug; 83(8):657-67. PubMed ID: 18508326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of exercise on serum markers of altered erythropoiesis and the indirect detection models of recombinant human erythropoietin abuse in athletes.
    Schumacher YO; Temme J; Bueltermann D; Schmid A; Berg A
    Haematologica; 2003 Jun; 88(6):712-4. PubMed ID: 12801849
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood transfusion in sports.
    Giraud S; Sottas PE; Robinson N; Saugy M
    Handb Exp Pharmacol; 2010; (195):295-304. PubMed ID: 20020370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications and biomonitoring issues of recombinant erythropoietins for doping control.
    Tsitsimpikou C; Kouretas D; Tsarouhas K; Fitch K; Spandidos DA; Tsatsakis A
    Ther Drug Monit; 2011 Feb; 33(1):3-13. PubMed ID: 21099742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of di(2-ethylhexyl)phthalate blood levels for blood transfusion detection.
    Varlet-Marie E; J Ashenden M; Moerkeberg J; Vela C; Audran M
    Bioanalysis; 2014; 6(12):1591-5. PubMed ID: 25077620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study.
    Pottgiesser T; Sottas PE; Echteler T; Robinson N; Umhau M; Schumacher YO
    Transfusion; 2011 Aug; 51(8):1707-15. PubMed ID: 21382045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.
    Schumacher YO; Saugy M; Pottgiesser T; Robinson N
    Drug Test Anal; 2012 Nov; 4(11):846-53. PubMed ID: 22374784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood doping: risks to athletes' health and strategies for detection.
    Oliveira CD; Bairros AV; Yonamine M
    Subst Use Misuse; 2014 Jul; 49(9):1168-81. PubMed ID: 24766400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of common hematologic abnormalities on the ability of blood models to detect erythropoietin abuse by athletes.
    Parisotto R; Ashenden MJ; Gore CJ; Sharpe K; Hopkins W; Hahn AG
    Haematologica; 2003 Aug; 88(8):931-40. PubMed ID: 12935982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous Blood Transfusion in Sports: Emerging Biomarkers.
    Salamin O; De Angelis S; Tissot JD; Saugy M; Leuenberger N
    Transfus Med Rev; 2016 Jul; 30(3):109-15. PubMed ID: 27260108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes.
    Ashenden MJ; Gore CJ; Parisotto R; Sharpe K; Hopkins WG; Hahn AG
    Haematologica; 2003 Sep; 88(9):1053-62. PubMed ID: 12969814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.